Medpace Holdings, Inc. (FRA:01P)

Germany · Delayed Price · Currency is EUR

498.20

-7.40 (-1.46%)

At close: Jan 27, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Oncology Revenue	719.84M	651.24M
Metabolic Revenue	618.01M	457.54M
Other Sources of Revenue	423.48M	431.38M
Cardiology Revenue	234.64M	230.45M
Central Nervous System Revenue	230.88M	181.98M
AVAI Revenue	131.53M	156.46M
Revenue (Total)	2.36B	2.11B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net New Business Awards	2.44B	2.23B
Total Backlog	3.00B	2.90B

Updated Sep 30, 2025. Data Source: Fiscal.ai.